Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Noninvasive Sweat-Lactate Biosensor Emplsoying a Hydrogel-Based Touch Pad.

Nagamine K, Mano T, Nomura A, Ichimura Y, Izawa R, Furusawa H, Matsui H, Kumaki D, Tokito S.

Sci Rep. 2019 Jul 12;9(1):10102. doi: 10.1038/s41598-019-46611-z.

2.

[Primary Adenocarcinoma of the Bladder at the Vesicocutaneostomy Site Occuring 30 Years after the Operation].

Sagehashi R, Ichimura Y, Iinuma M.

Hinyokika Kiyo. 2019 May;65(5):167-170. doi: 10.14989/ActaUrolJap_65_5_167. Japanese.

PMID:
31247695
3.

Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment.

Higuchi T, Takagi K, Tochimoto A, Ichimura Y, Norose T, Katsumata Y, Masuda I, Yamanaka H, Morohoshi T, Kawaguchi Y.

Arthritis Res Ther. 2019 Apr 18;21(1):103. doi: 10.1186/s13075-019-1881-3.

4.

Seasonal differences in rumen bacterial flora of wild Hokkaido sika deer and partial characterization of an unknown bacterial group possibly involved in fiber digestion in winter.

Yamano H, Ichimura Y, Sawabe Y, Koike S, Suzuki Y, Kobayashi Y.

Anim Sci J. 2019 Jun;90(6):790-798. doi: 10.1111/asj.13203. Epub 2019 Apr 14.

PMID:
30983093
5.

Autophagy regulates lipid metabolism through selective turnover of NCoR1.

Saito T, Kuma A, Sugiura Y, Ichimura Y, Obata M, Kitamura H, Okuda S, Lee HC, Ikeda K, Kanegae Y, Saito I, Auwerx J, Motohashi H, Suematsu M, Soga T, Yokomizo T, Waguri S, Mizushima N, Komatsu M.

Nat Commun. 2019 Apr 5;10(1):1567. doi: 10.1038/s41467-019-08829-3.

6.

Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study.

Sumida H, Asano Y, Tamaki Z, Aozasa N, Taniguchi T, Toyama T, Takahashi T, Ichimura Y, Noda S, Akamata K, Saigusa R, Miyazaki M, Kuwano Y, Yanaba K, Yoshizaki A, Sato S.

J Dermatol. 2018 Dec;45(12):1425-1433. doi: 10.1111/1346-8138.14669. Epub 2018 Oct 5.

PMID:
30289572
7.

Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.

Yamashita T, Asano Y, Saigusa R, Taniguchi T, Nakamura K, Miura S, Toyama T, Takahashi T, Ichimura Y, Hirabayashi M, Yoshizaki A, Miyagaki T, Sugaya M, Sato S.

J Dermatol Sci. 2019 Jan;93(1):24-32. doi: 10.1016/j.jdermsci.2018.09.007. Epub 2018 Sep 21.

PMID:
30270117
8.

Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized scleroderma.

Miyagawa T, Ichimura Y, Nakamura K, Hirabayashi M, Yamashita T, Saigusa R, Miura S, Takahashi T, Toyama T, Taniguchi T, Akamata K, Yoshizaki A, Sato S, Asano Y.

J Dermatol Sci. 2018 Nov;92(2):207-214. doi: 10.1016/j.jdermsci.2018.09.005. Epub 2018 Sep 19.

PMID:
30268392
9.

Assessment of endothelial function during the loading phase of infliximab in psoriasis: a potential predictor of its drug survival.

Nakao M, Nakamura K, Fukasawa T, Shida R, Ito A, Ichimura Y, Takahashi T, Mitsui A, Yoshizaki A, Shibata S, Kamata M, Araki M, Watanabe R, Sato S, Asano Y.

Int J Dermatol. 2019 Jan;58(1):54-59. doi: 10.1111/ijd.14200. Epub 2018 Aug 31.

PMID:
30168849
10.

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: A systematic review.

Tanabe N, Kawakami T, Satoh T, Matsubara H, Nakanishi N, Ogino H, Tamura Y, Tsujino I, Ogawa A, Sakao S, Nishizaki M, Ishida K, Ichimura Y, Yoshida M, Tatsumi K.

Respir Investig. 2018 Jul;56(4):332-341. doi: 10.1016/j.resinv.2018.03.004. Epub 2018 Jul 3.

PMID:
30008295
11.

CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.

Taniguchi T, Miyagawa T, Toyama S, Yamashita T, Nakamura K, Saigusa R, Ichimura Y, Takahashi T, Toyama T, Yoshizaki A, Sato S, Asano Y.

Exp Dermatol. 2018 Sep;27(9):1030-1037. doi: 10.1111/exd.13724. Epub 2018 Jul 29.

PMID:
29947047
12.

Activation of p62/SQSTM1-Keap1-Nuclear Factor Erythroid 2-Related Factor 2 Pathway in Cancer.

Ichimura Y, Komatsu M.

Front Oncol. 2018 Jun 7;8:210. doi: 10.3389/fonc.2018.00210. eCollection 2018. Review.

13.

Biallelic UFM1 and UFC1 mutations expand the essential role of ufmylation in brain development.

Nahorski MS, Maddirevula S, Ishimura R, Alsahli S, Brady AF, Begemann A, Mizushima T, Guzmán-Vega FJ, Obata M, Ichimura Y, Alsaif HS, Anazi S, Ibrahim N, Abdulwahab F, Hashem M, Monies D, Abouelhoda M, Meyer BF, Alfadhel M, Eyaid W, Zweier M, Steindl K, Rauch A, Arold ST, Woods CG, Komatsu M, Alkuraya FS.

Brain. 2018 Jul 1;141(7):1934-1945. doi: 10.1093/brain/awy135.

14.

Linear immunoglobulin A bullous dermatosis limited to oral mucosa associated with ulcerative colitis.

Oka T, Miyagaki T, Isomura S, Ichimura Y, Kamata M, Mitsui H, Ishii N, Hashimoto T, Sato S.

J Dermatol. 2018 Oct;45(10):e281-e282. doi: 10.1111/1346-8138.14326. Epub 2018 Apr 14. No abstract available.

PMID:
29655262
15.

Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.

Saigusa R, Asano Y, Taniguchi T, Hirabayashi M, Nakamura K, Miura S, Yamashita T, Takahashi T, Ichimura Y, Toyama T, Yoshizaki A, Trojanowska M, Sato S.

Arthritis Res Ther. 2018 Feb 7;20(1):23. doi: 10.1186/s13075-018-1521-3.

16.

Capillary abnormalities observed by nailfold video-capillaroscopy in Japanese patients with systemic sclerosis.

Ichimura Y, Kawaguchi Y, Takagi K, Tochimoto A, Higuchi T, Kataoka S, Katsumata Y, Yamanaka H.

Mod Rheumatol. 2018 Nov;28(6):1066-1068. doi: 10.1080/14397595.2018.1430547. Epub 2018 Feb 8. No abstract available.

PMID:
29357721
17.

Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant.

Kageyama S, Saito T, Obata M, Koide RH, Ichimura Y, Komatsu M.

Mol Cell Biol. 2018 Mar 15;38(7). pii: e00642-17. doi: 10.1128/MCB.00642-17. Print 2018 Apr 1.

18.

Systemic sclerosis complicated with localized scleroderma-like lesions induced by Köbner phenomenon.

Saigusa R, Asano Y, Yamashita T, Takahashi T, Nakamura K, Miura S, Ichimura Y, Toyama T, Taniguchi T, Sumida H, Tamaki Z, Miyazaki M, Yoshizaki A, Sato S.

J Dermatol Sci. 2018 Mar;89(3):282-289. doi: 10.1016/j.jdermsci.2017.12.005. Epub 2017 Dec 16.

PMID:
29279288
19.

Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosis.

Hirabayashi M, Asano Y, Yamashita T, Miura S, Nakamura K, Taniguchi T, Saigusa R, Takahashi T, Ichimura Y, Miyagawa T, Yoshizaki A, Miyagaki T, Sugaya M, Sato S.

J Dermatol. 2018 Feb;45(2):182-188. doi: 10.1111/1346-8138.14088. Epub 2017 Oct 17.

PMID:
29044628
20.

A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.

Taniguchi T, Miyagawa T, Tamaki Z, Nakamura K, Yamashita T, Saigusa R, Takahashi T, Toyama T, Ichimura Y, Yoshizaki A, Tada Y, Sugaya M, Kadono T, Sato S, Asano Y.

Arch Dermatol Res. 2017 Dec;309(10):833-842. doi: 10.1007/s00403-017-1786-4. Epub 2017 Oct 16.

PMID:
29038846
21.

Discovery of benzo[g]indoles as a novel class of non-covalent Keap1-Nrf2 protein-protein interaction inhibitor.

Yasuda D, Yuasa A, Obata R, Nakajima M, Takahashi K, Ohe T, Ichimura Y, Komatsu M, Yamamoto M, Imamura R, Kojima H, Okabe T, Nagano T, Mashino T.

Bioorg Med Chem Lett. 2017 Nov 15;27(22):5006-5009. doi: 10.1016/j.bmcl.2017.10.008. Epub 2017 Oct 6.

PMID:
29037947
22.

The effects of pirfenidone in patients with an acute exacerbation of interstitial pneumonia.

Matsumura T, Tsushima K, Abe M, Suzuki K, Yamagishi K, Matsumura A, Ichimura Y, Ikari J, Terada J, Tatsumi K.

Clin Respir J. 2018 Apr;12(4):1550-1558. doi: 10.1111/crj.12704. Epub 2017 Sep 27.

PMID:
28876508
23.

Papillotubular carcinoma with an invasive micropapillary carcinoma component of the breast, characterized by a rapid increase in size due to intra-tumoral hemorrhage: A case report.

Watanabe M, Matsuoka R, Ichimura Y, Takagaki T, Iitsuka Y.

Int J Surg Case Rep. 2017;38:189-191. doi: 10.1016/j.ijscr.2017.07.048. Epub 2017 Jul 25.

24.

A potential contribution of psoriasin to vascular and epithelial abnormalities and inflammation in systemic sclerosis.

Takahashi T, Asano Y, Yamashita T, Nakamura K, Saigusa R, Miura S, Ichimura Y, Toyama T, Hirabayashi M, Taniguchi T, Yoshizaki A, Sato S.

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):291-297. doi: 10.1111/jdv.14459. Epub 2017 Aug 3.

PMID:
28681537
25.

Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis.

Fukasawa T, Yoshizaki A, Ebata S, Nakamura K, Saigusa R, Miura S, Yamashita T, Hirabayashi M, Ichimura Y, Taniguchi T, Asano Y, Shimizu H, Kazoe Y, Mawatari K, Kitamori T, Sato S.

Arthritis Rheumatol. 2017 Sep;69(9):1879-1890. doi: 10.1002/art.40164. Epub 2017 Aug 1.

26.

Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency.

Saigusa R, Asano Y, Nakamura K, Hirabayashi M, Miura S, Yamashita T, Taniguchi T, Ichimura Y, Takahashi T, Yoshizaki A, Miyagaki T, Sugaya M, Sato S.

J Invest Dermatol. 2017 Sep;137(9):1850-1859. doi: 10.1016/j.jid.2017.04.035. Epub 2017 May 18.

27.

Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.

Taniguchi T, Asano Y, Nakamura K, Yamashita T, Saigusa R, Ichimura Y, Takahashi T, Toyama T, Yoshizaki A, Sato S.

J Rheumatol. 2017 Aug;44(8):1198-1205. doi: 10.3899/jrheum.161092. Epub 2017 May 15.

28.

Serum H-ficolin levels: Clinical association with interstitial lung disease in patients with systemic sclerosis.

Miyagawa T, Asano Y, de Mestier Y, Saigusa R, Taniguchi T, Yamashita T, Nakamura K, Hirabayashi M, Miura S, Ichimura Y, Takahashi T, Yoshizaki A, Miyagaki T, Sugaya M, Sato S.

J Dermatol. 2017 Oct;44(10):1168-1171. doi: 10.1111/1346-8138.13877. Epub 2017 Apr 22.

PMID:
28432700
29.

The impact of transcription factor Fli1 deficiency on the regulation of angiogenesis.

Toyama T, Asano Y, Miyagawa T, Nakamura K, Hirabayashi M, Yamashita T, Saigusa R, Miura S, Ichimura Y, Takahashi T, Taniguchi T, Yoshizaki A, Sato S.

Exp Dermatol. 2017 Oct;26(10):912-918. doi: 10.1111/exd.13341. Epub 2017 Jul 10.

PMID:
28370536
30.

Thymoma-associated multi-organ autoimmunity: A case of graft-versus-host disease-like erythroderma complicated by Good syndrome successfully treated by thymectomy.

Fukushima A, Ichimura Y, Obata S, Kinoshita-Ise M, Fujio Y, Takeno M, Konohana I.

J Dermatol. 2017 Jul;44(7):830-835. doi: 10.1111/1346-8138.13777. Epub 2017 Mar 3.

PMID:
28256733
31.

Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma.

Takahashi T, Asano Y, Sugawara K, Yamashita T, Nakamura K, Saigusa R, Ichimura Y, Toyama T, Taniguchi T, Akamata K, Noda S, Yoshizaki A, Tsuruta D, Trojanowska M, Sato S.

J Exp Med. 2017 Apr 3;214(4):1129-1151. doi: 10.1084/jem.20160247. Epub 2017 Feb 23.

32.

Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease.

Terasaki Y, Ikushima S, Matsui S, Hebisawa A, Ichimura Y, Izumi S, Ujita M, Arita M, Tomii K, Komase Y, Owan I, Kawamura T, Matsuzawa Y, Murakami M, Ishimoto H, Kimura H, Bando M, Nishimoto N, Kawabata Y, Fukuda Y, Ogura T; Tokyo Diffuse Lung Diseases Study Group.

Histopathology. 2017 Jun;70(7):1114-1124. doi: 10.1111/his.13186. Epub 2017 Apr 3.

PMID:
28207938
33.

Quality control in QuantiFERON-TB gold in-tube for screening latent tuberculosis infection in health care workers.

Igari H, Watanabe A, Ichimura Y, Sakurai T, Taniguchi T, Ishiwada N.

J Infect Chemother. 2017 Apr;23(4):211-213. doi: 10.1016/j.jiac.2016.12.006. Epub 2017 Jan 13.

PMID:
28094124
34.

Ethosuximide-induced lupus-scleroderma syndrome with disease-specific autoantibodies.

Toyama T, Asano Y, Taniguchi T, Takahashi T, Ichimura Y, Tamaki Z, Kagami S, Mitsui H, Sato S.

Eur J Dermatol. 2017 Apr 1;27(2):196-197. doi: 10.1684/ejd.2016.2942. No abstract available.

PMID:
28026802
35.

Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease.

Ebata S, Yoshizaki A, Fukasawa T, Nakamura K, Yamashita T, Miura S, Saigusa R, Ichimura Y, Takahashi T, Hirabayashi M, Taniguchi T, Akamata K, Asano Y, Sato S.

Scand J Rheumatol. 2017 May;46(3):247-252. doi: 10.1080/03009742.2016.1231341. Epub 2016 Nov 30. No abstract available.

PMID:
27900875
36.

Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity.

Yasuda D, Nakajima M, Yuasa A, Obata R, Takahashi K, Ohe T, Ichimura Y, Komatsu M, Yamamoto M, Imamura R, Kojima H, Okabe T, Nagano T, Mashino T.

Bioorg Med Chem Lett. 2016 Dec 15;26(24):5956-5959. doi: 10.1016/j.bmcl.2016.10.083. Epub 2016 Oct 27.

PMID:
27839920
37.

Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.

Yamashita T, Asano Y, Taniguchi T, Nakamura K, Saigusa R, Miura S, Toyama T, Takahashi T, Ichimura Y, Yoshizaki A, Trojanowska M, Sato S.

J Invest Dermatol. 2017 Mar;137(3):631-640. doi: 10.1016/j.jid.2016.08.037. Epub 2016 Oct 21.

38.

Autophagy linked FYVE (Alfy/WDFY3) is required for establishing neuronal connectivity in the mammalian brain.

Dragich JM, Kuwajima T, Hirose-Ikeda M, Yoon MS, Eenjes E, Bosco JR, Fox LM, Lystad AH, Oo TF, Yarygina O, Mita T, Waguri S, Ichimura Y, Komatsu M, Simonsen A, Burke RE, Mason CA, Yamamoto A.

Elife. 2016 Sep 20;5. pii: e14810. doi: 10.7554/eLife.14810.

39.

Biallelic Variants in UBA5 Link Dysfunctional UFM1 Ubiquitin-like Modifier Pathway to Severe Infantile-Onset Encephalopathy.

Muona M, Ishimura R, Laari A, Ichimura Y, Linnankivi T, Keski-Filppula R, Herva R, Rantala H, Paetau A, Pöyhönen M, Obata M, Uemura T, Karhu T, Bizen N, Takebayashi H, McKee S, Parker MJ, Akawi N, McRae J, Hurles ME; DDD Study, Kuismin O, Kurki MI, Anttonen AK, Tanaka K, Palotie A, Waguri S, Lehesjoki AE, Komatsu M.

Am J Hum Genet. 2016 Sep 1;99(3):683-694. doi: 10.1016/j.ajhg.2016.06.020. Epub 2016 Aug 18.

40.

Plasma plasmin-α2-plasmin inhibitor complex levels may predict the effect of cyclophosphamide for systemic sclerosis-related interstitial lung disease.

Saigusa R, Asano Y, Nakamura K, Yamashita T, Ichimura Y, Takahashi T, Toyama T, Taniguchi T, Yoshizaki A, Miyazaki M, Tamaki Z, Sato S.

Mod Rheumatol. 2017 Jul;27(4):618-622. doi: 10.1080/14397595.2016.1226472. Epub 2016 Sep 13.

PMID:
27538472
41.

Correlations between Plasma Levels of Anionic Uremic Toxins and Clinical Parameters in Hemodialysis Patients.

Ichimura Y, Takamatsu H, Ideuchi H, Oda M, Takeda K, Saitoh H.

Yakugaku Zasshi. 2016;136(8):1177-84. doi: 10.1248/yakushi.15-00252.

42.

Congenital diaphragmatic hernia manifesting after an altitude flight.

Watanabe M, Ichimura Y, Takagaki T, Iitsuka Y.

Surgery. 2017 Jun;161(6):1741-1742. doi: 10.1016/j.surg.2016.05.013. Epub 2016 Jun 29. No abstract available.

PMID:
27372522
43.

p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming.

Saito T, Ichimura Y, Taguchi K, Suzuki T, Mizushima T, Takagi K, Hirose Y, Nagahashi M, Iso T, Fukutomi T, Ohishi M, Endo K, Uemura T, Nishito Y, Okuda S, Obata M, Kouno T, Imamura R, Tada Y, Obata R, Yasuda D, Takahashi K, Fujimura T, Pi J, Lee MS, Ueno T, Ohe T, Mashino T, Wakai T, Kojima H, Okabe T, Nagano T, Motohashi H, Waguri S, Soga T, Yamamoto M, Tanaka K, Komatsu M.

Nat Commun. 2016 Jun 27;7:12030. doi: 10.1038/ncomms12030.

44.

Assessment of predictors of insulin therapy in patients with gestational diabetes diagnosed according to the IADPSG criteria.

Yanagisawa K, Muraoka M, Takagi K, Ichimura Y, Kambara M, Sato A, Sakura H, Uchigata Y.

Diabetol Int. 2016 May 4;7(4):440-446. doi: 10.1007/s13340-016-0272-0. eCollection 2016 Dec.

45.

A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis.

Takahashi T, Asano Y, Nakamura K, Yamashita T, Saigusa R, Ichimura Y, Toyama T, Taniguchi T, Yoshizaki A, Tamaki Z, Tada Y, Sugaya M, Kadono T, Sato S.

Br J Dermatol. 2016 Dec;175(6):1195-1203. doi: 10.1111/bjd.14699. Epub 2016 Aug 30.

PMID:
27105895
46.

Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells.

Toyama T, Asano Y, Akamata K, Noda S, Taniguchi T, Takahashi T, Ichimura Y, Shudo K, Sato S, Kadono T.

J Invest Dermatol. 2016 Feb;136(2):387-398. doi: 10.1016/j.jid.2015.10.058. Epub 2015 Nov 18.

47.

Structural and Functional Analysis of a Novel Interaction Motif within UFM1-activating Enzyme 5 (UBA5) Required for Binding to Ubiquitin-like Proteins and Ufmylation.

Habisov S, Huber J, Ichimura Y, Akutsu M, Rogova N, Loehr F, McEwan DG, Johansen T, Dikic I, Doetsch V, Komatsu M, Rogov VV, Kirkin V.

J Biol Chem. 2016 Apr 22;291(17):9025-41. doi: 10.1074/jbc.M116.715474. Epub 2016 Feb 29.

48.

Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis.

Saigusa R, Asano Y, Nakamura K, Yamashita T, Ichimura Y, Takahashi T, Toyama T, Taniguchi T, Yoshizaki A, Miyazaki M, Tamaki Z, Sato S.

J Dermatol. 2016 Jul;43(7):808-10. doi: 10.1111/1346-8138.13292. Epub 2016 Feb 15.

PMID:
26876001
49.

Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis.

Nakamura K, Asano Y, Taniguchi T, Minatsuki S, Inaba T, Maki H, Hatano M, Yamashita T, Saigusa R, Ichimura Y, Takahashi T, Toyama T, Yoshizaki A, Miyagaki T, Sugaya M, Sato S.

J Dermatol. 2016 Aug;43(8):912-8. doi: 10.1111/1346-8138.13252. Epub 2016 Jan 18.

PMID:
26777734
50.

A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.

Yamashita T, Asano Y, Taniguchi T, Nakamura K, Saigusa R, Takahashi T, Ichimura Y, Toyama T, Yoshizaki A, Miyagaki T, Sugaya M, Sato S.

Exp Dermatol. 2016 Apr;25(4):287-92. doi: 10.1111/exd.12920. Epub 2016 Feb 11.

PMID:
26661692

Supplemental Content

Loading ...
Support Center